Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo

Z. N. Zhou, Ved P. Sharma, B. T. Beaty, M. Roh-Johnson, E. A. Peterson, N. Van Rooijen, P. A. Kenny, H. S. Wiley, John S. Condeelis, Jeffrey E. Segall

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Increased expression of HBEGF in estrogen receptor-negative breast tumors is correlated with enhanced metastasis to distant organ sites and more rapid disease recurrence upon removal of the primary tumor. Our previous work has demonstrated a paracrine loop between breast cancer cells and macrophages in which the tumor cells are capable of stimulating macrophages through the secretion of colony-stimulating factor-1 while the tumor-Associated macrophages (TAMs), in turn, aid in tumor cell invasion by secreting epidermal growth factor. To determine how the autocrine expression of epidermal growth factor receptor (EGFR) ligands by carcinoma cells would affect this paracrine loop mechanism, and in particular whether tumor cell invasion depends on spatial ligand gradients generated by TAMs, we generated cell lines with increased HBEGF expression. We found that autocrine HBEGF expression enhanced in vivo intravasation and metastasis and resulted in a novel phenomenon in which macrophages were no longer required for in vivo invasion of breast cancer cells. In vitro studies revealed that expression of HBEGF enhanced invadopodium formation, thus providing a mechanism for cell autonomous invasion. The increased invadopodium formation was directly dependent on EGFR signaling, as demonstrated by a rapid decrease in invadopodia upon inhibition of autocrine HBEGF/EGFR signaling as well as inhibition of signaling downstream of EGFR activation. HBEGF expression also resulted in enhanced invadopodium function via upregulation of matrix metalloprotease 2 (MMP2) and MMP9 expression levels. We conclude that high levels of HBEGF expression can short-circuit the tumor cell/macrophage paracrine invasion loop, resulting in enhanced tumor invasion that is independent of macrophage signaling.

Original languageEnglish (US)
Pages (from-to)3784-3793
Number of pages10
JournalOncogene
Volume33
Issue number29
DOIs
StatePublished - Jul 17 2014

Fingerprint

Macrophages
Breast Neoplasms
Neoplasm Metastasis
Epidermal Growth Factor Receptor
Neoplasms
Ligands
Macrophage Colony-Stimulating Factor
Metalloproteases
Epidermal Growth Factor
Estrogen Receptors
Up-Regulation
Carcinoma
Recurrence
Cell Line
Podosomes

Keywords

  • breast cancer invasion
  • EGFR
  • HBEGF
  • metastasis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. / Zhou, Z. N.; Sharma, Ved P.; Beaty, B. T.; Roh-Johnson, M.; Peterson, E. A.; Van Rooijen, N.; Kenny, P. A.; Wiley, H. S.; Condeelis, John S.; Segall, Jeffrey E.

In: Oncogene, Vol. 33, No. 29, 17.07.2014, p. 3784-3793.

Research output: Contribution to journalArticle

Zhou, Z. N. ; Sharma, Ved P. ; Beaty, B. T. ; Roh-Johnson, M. ; Peterson, E. A. ; Van Rooijen, N. ; Kenny, P. A. ; Wiley, H. S. ; Condeelis, John S. ; Segall, Jeffrey E. / Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. In: Oncogene. 2014 ; Vol. 33, No. 29. pp. 3784-3793.
@article{a5094909c8cb499c9c733510222d65ac,
title = "Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo",
abstract = "Increased expression of HBEGF in estrogen receptor-negative breast tumors is correlated with enhanced metastasis to distant organ sites and more rapid disease recurrence upon removal of the primary tumor. Our previous work has demonstrated a paracrine loop between breast cancer cells and macrophages in which the tumor cells are capable of stimulating macrophages through the secretion of colony-stimulating factor-1 while the tumor-Associated macrophages (TAMs), in turn, aid in tumor cell invasion by secreting epidermal growth factor. To determine how the autocrine expression of epidermal growth factor receptor (EGFR) ligands by carcinoma cells would affect this paracrine loop mechanism, and in particular whether tumor cell invasion depends on spatial ligand gradients generated by TAMs, we generated cell lines with increased HBEGF expression. We found that autocrine HBEGF expression enhanced in vivo intravasation and metastasis and resulted in a novel phenomenon in which macrophages were no longer required for in vivo invasion of breast cancer cells. In vitro studies revealed that expression of HBEGF enhanced invadopodium formation, thus providing a mechanism for cell autonomous invasion. The increased invadopodium formation was directly dependent on EGFR signaling, as demonstrated by a rapid decrease in invadopodia upon inhibition of autocrine HBEGF/EGFR signaling as well as inhibition of signaling downstream of EGFR activation. HBEGF expression also resulted in enhanced invadopodium function via upregulation of matrix metalloprotease 2 (MMP2) and MMP9 expression levels. We conclude that high levels of HBEGF expression can short-circuit the tumor cell/macrophage paracrine invasion loop, resulting in enhanced tumor invasion that is independent of macrophage signaling.",
keywords = "breast cancer invasion, EGFR, HBEGF, metastasis",
author = "Zhou, {Z. N.} and Sharma, {Ved P.} and Beaty, {B. T.} and M. Roh-Johnson and Peterson, {E. A.} and {Van Rooijen}, N. and Kenny, {P. A.} and Wiley, {H. S.} and Condeelis, {John S.} and Segall, {Jeffrey E.}",
year = "2014",
month = "7",
day = "17",
doi = "10.1038/onc.2013.363",
language = "English (US)",
volume = "33",
pages = "3784--3793",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "29",

}

TY - JOUR

T1 - Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo

AU - Zhou, Z. N.

AU - Sharma, Ved P.

AU - Beaty, B. T.

AU - Roh-Johnson, M.

AU - Peterson, E. A.

AU - Van Rooijen, N.

AU - Kenny, P. A.

AU - Wiley, H. S.

AU - Condeelis, John S.

AU - Segall, Jeffrey E.

PY - 2014/7/17

Y1 - 2014/7/17

N2 - Increased expression of HBEGF in estrogen receptor-negative breast tumors is correlated with enhanced metastasis to distant organ sites and more rapid disease recurrence upon removal of the primary tumor. Our previous work has demonstrated a paracrine loop between breast cancer cells and macrophages in which the tumor cells are capable of stimulating macrophages through the secretion of colony-stimulating factor-1 while the tumor-Associated macrophages (TAMs), in turn, aid in tumor cell invasion by secreting epidermal growth factor. To determine how the autocrine expression of epidermal growth factor receptor (EGFR) ligands by carcinoma cells would affect this paracrine loop mechanism, and in particular whether tumor cell invasion depends on spatial ligand gradients generated by TAMs, we generated cell lines with increased HBEGF expression. We found that autocrine HBEGF expression enhanced in vivo intravasation and metastasis and resulted in a novel phenomenon in which macrophages were no longer required for in vivo invasion of breast cancer cells. In vitro studies revealed that expression of HBEGF enhanced invadopodium formation, thus providing a mechanism for cell autonomous invasion. The increased invadopodium formation was directly dependent on EGFR signaling, as demonstrated by a rapid decrease in invadopodia upon inhibition of autocrine HBEGF/EGFR signaling as well as inhibition of signaling downstream of EGFR activation. HBEGF expression also resulted in enhanced invadopodium function via upregulation of matrix metalloprotease 2 (MMP2) and MMP9 expression levels. We conclude that high levels of HBEGF expression can short-circuit the tumor cell/macrophage paracrine invasion loop, resulting in enhanced tumor invasion that is independent of macrophage signaling.

AB - Increased expression of HBEGF in estrogen receptor-negative breast tumors is correlated with enhanced metastasis to distant organ sites and more rapid disease recurrence upon removal of the primary tumor. Our previous work has demonstrated a paracrine loop between breast cancer cells and macrophages in which the tumor cells are capable of stimulating macrophages through the secretion of colony-stimulating factor-1 while the tumor-Associated macrophages (TAMs), in turn, aid in tumor cell invasion by secreting epidermal growth factor. To determine how the autocrine expression of epidermal growth factor receptor (EGFR) ligands by carcinoma cells would affect this paracrine loop mechanism, and in particular whether tumor cell invasion depends on spatial ligand gradients generated by TAMs, we generated cell lines with increased HBEGF expression. We found that autocrine HBEGF expression enhanced in vivo intravasation and metastasis and resulted in a novel phenomenon in which macrophages were no longer required for in vivo invasion of breast cancer cells. In vitro studies revealed that expression of HBEGF enhanced invadopodium formation, thus providing a mechanism for cell autonomous invasion. The increased invadopodium formation was directly dependent on EGFR signaling, as demonstrated by a rapid decrease in invadopodia upon inhibition of autocrine HBEGF/EGFR signaling as well as inhibition of signaling downstream of EGFR activation. HBEGF expression also resulted in enhanced invadopodium function via upregulation of matrix metalloprotease 2 (MMP2) and MMP9 expression levels. We conclude that high levels of HBEGF expression can short-circuit the tumor cell/macrophage paracrine invasion loop, resulting in enhanced tumor invasion that is independent of macrophage signaling.

KW - breast cancer invasion

KW - EGFR

KW - HBEGF

KW - metastasis

UR - http://www.scopus.com/inward/record.url?scp=84904676581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904676581&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.363

DO - 10.1038/onc.2013.363

M3 - Article

C2 - 24013225

AN - SCOPUS:84904676581

VL - 33

SP - 3784

EP - 3793

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 29

ER -